Nanograb Analysis
What is Nanograb?
Nanograb is a computational drug discovery company utilizing AI to create targeted drug combinations for treating various diseases.
Employees
3
Founded
2023
Company Stage
Pre-Seed
Product Features & Capabilities
- Multivalent nanoparticles, AI-generated drug combinations, targeted drug delivery to specific body areas.
Who are the founders of Nanograb
DM
Business Model
AI-driven drug discovery with subscription-based revenue model and growth in user base.
Market Focus
Nanograb primarily focuses on the computational drug discovery industry, utilizing AI to develop targeted treatments for various diseases.
Investors
- Imperial College London
- Imperial Enterprise Lab
- Y Combinator
- Sterling Road
- Recode Ventures
Competitors Overview
Nanograb operates in the computational drug discovery market, utilizing AI to create targeted drug therapies. Its main competitors include:
- Atomwise: Specializes in using AI for drug discovery, particularly in predicting how small molecules will interact with proteins. Atomwise's advantage l
See something that needs updating? Suggest edits to this profile.